-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
-
Summary
-
Spruce Biosciences, Inc. quarterly/annual Net Cash Provided by (Used in) Investing Activities history and growth rate from Q1 2021 to Q1 2024.
- Spruce Biosciences, Inc. Net Cash Provided by (Used in) Investing Activities for the quarter ending March 31, 2024 was $0.000, a 100% decline year-over-year.
- Spruce Biosciences, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2023 was $55.8M, a 135% increase from 2022.
- Spruce Biosciences, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2022 was $23.7M.
- Spruce Biosciences, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2021 was -$79.2M, a 106884% decline from 2020.
Net Cash Provided by (Used in) Investing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Quarterly Growth (%)